Search results
Showing 251 to 300 of 1359 results for patients and public
Highly specialised technology (HST) evaluations are recommendations on the use of new and existing highly specialised medicines and treatments within the NHS in England.
How people can have an impact on NICE guidance
In development [GID-TA10568] Expected publication date: TBC
This guideline sets out an antimicrobial prescribing strategy for acute cough associated with an upper respiratory tract infection or acute bronchitis in adults, young people and children. It aims to limit antibiotic use and reduce antibiotic resistance.
Eculizumab for treating atypical haemolytic uraemic syndrome (HST1)
Evidence-based recommendations on eculizumab (Soliris) for treating atypical haemolytic uraemic syndrome in adults and children.
This guideline sets out an antimicrobial prescribing strategy for secondary bacterial infection of eczema and covers infection of other common skin conditions. It aims to optimise antibiotic use and reduce antibiotic resistance. The recommendations are for adults, young people and children aged 72 hours and over. They do not cover diagnosis.
Complicated urinary tract infections: ceftolozane/tazobactam (ESNM74)
Summary of the evidence on ceftolozane/tazobactam for treating complicated urinary tract infections to inform local NHS planning and decision-making
This quality standard covers increasing vaccine uptake among children and young people aged under 19 in groups and settings that have low immunisation coverage. It describes high-quality care in priority areas for improvement.
View quality statements for QS145Show all sections
Sections for QS145
- Quality statements
- Quality statement 1: Follow-up invitations
- Quality statement 2: Offering outstanding vaccinations
- Quality statement 3: Recording vaccinations
- Quality statement 4: Checking immunisation status at specific educational stages
- Quality statement 5: Checking immunisation status of young offenders and offering outstanding vaccinations
- Update information
- About this quality standard
the service also runs a 7/7 Ambulatory Detoxification clinic flexible to patient's needs - this is based at the Hospital. The Team are...
covered in the evaluation, or who treat patients identified by the diagnostic technologies. A national patient or carer...
This guide describes the methods and processes, including expected timescales, that NICE follows when carrying out health technology evaluations. The methods and processes are designed to produce robust guidance for the NHS in an open, transparent and timely way, with appropriate contribution from stakeholders. Organisations invited to contribute to health technology evaluation development should read this manual in conjunction with the NICE health technology evaluation topic selection: the manual. All documents are available on the NICE website.
Awaiting development [GID-TA10957] Expected publication date: TBC
Get expert advice and support from NICE International, part of the UK’s National Institute for Health and Care Excellence, for a project in your country
Guidance Executive
This quality standard covers diagnosing and managing hip fracture in adults (aged 18 and over). It describes high-quality care in priority areas for improvement.
View quality statements for QS16Show all sections
Sections for QS16
- Quality statements
- Quality statement 1: Multidisciplinary management
- Quality statement 2: Timing and expertise for surgery
- Quality statement 3: Intracapsular fracture
- Quality statement 4: Trochanteric fracture
- Quality statement 5: Subtrochanteric fracture
- Quality statement 6: Rehabilitation after surgery
- Update information
This guideline covers interventions to prevent sexually transmitted infections (STIs) in people aged 16 and over. It aims to reduce the transmission of all STIs, including HIV, and includes ways to help increase the uptake of STI testing and vaccines for human papillomavirus (HPV) and hepatitis A and B.
management of patients with OA and long term conditions (LTCs). This project aimed to address the unmet needs of healthcare...
How we collect and use your personal information, and your rights under data protection legislation
NHS Trust), CCG (Dudley Clinical Commisioning Group), local authority and public health services (Dudley Metropolitan Borough Council)...
This quality standard covers services for domestic violence and abuse in adults and young people (aged 16 and over). It includes identifying and supporting people experiencing domestic violence or abuse, as well as support for those who carry it out. It also covers children and young people (under 16) who are affected by domestic violence or abuse that is not carried out against them. It describes high-quality care in priority areas for improvement.
View quality statements for QS116Show all sections
Sections for QS116
- Introduction
- List of quality statements
- Quality statement 1: Asking about domestic violence and abuse
- Quality statement 2: Response to domestic violence and abuse
- Quality statement 3: Referral to specialist support services for people experiencing domestic violence or abuse
- Quality statement 4: Referral to specialist services for people perpetrating domestic violence or abuse
- Using the quality standard
- Diversity, equality and language
Interim methods guide for developing good practice guidance (PMG15)
Interim methods guide for developing good practice guidance
Reversal of the anticoagulant effect of dabigatran: idarucizumab (ESNM73)
Summary of the evidence on idarucizumab for reversing the anticoagulant effect of dabigtatran to inform local NHS planning and decision-making
Members are appointed for a 3-year term, and are drawn from: the NHS patient and carer organisations academia pharmaceuticals and...
Everolimus with exemestane for treating advanced breast cancer after endocrine therapy (TA421)
Evidence-based recommendations on everolimus (Afinitor) for treating advanced breast cancer in adults after endocrine therapy.
Evidence-based recommendations on AI-derived computer-aided detection (CAD) software for detecting and measuring lung nodules in CT scan images
home rather than hospital and improves the length and quality of life for patients. Read news story
Clostridium difficile infection: risk with broad-spectrum antibiotics (ESMPB1)
Summary of the evidence on the risk of using broad-specturm antibiotics associated with clostridium difficile infection
Find out about the progress made by the health and care system in implementing NICE guidance on respiratory conditions
this would be helpful. Read our hints and tips when preparing to be a patient expert (PDF) for more information on taking part in our...
This quality standard covers preventing and controlling infection in adults, young people and children receiving healthcare in primary, community and secondary care settings. It includes preventing healthcare-associated infections that develop because of treatment or from being in a healthcare setting. It describes high-quality care in priority areas for improvement.
View quality statements for QS61Show all sections
Sections for QS61
- Quality statements
- Quality statement 1: Antimicrobial stewardship
- Quality statement 2: Organisational responsibility
- Quality statement 3: Hand decontamination
- Quality statement 4: Urinary catheters
- Quality statement 5: Vascular access devices
- Quality statement 6: Educating people about infection prevention and control
- Update information
This guideline sets out an antimicrobial prescribing strategy for acute prostatitis. It aims to optimise antibiotic use and reduce antibiotic resistance.
View recommendations for NG110Show all sections
objectives As part of the 0 - 19 healthy child service redesign Public Health Suffolk (in their capacity as commissioner of the service)...
A review of the impact our evidence-based guidance has on improvements in lung cancer.
Pembrolizumab for adjuvant treatment of resected non-small-cell lung cancer [ID3907]
In development [GID-TA10784] Expected publication date: 16 October 2024
Mental health of adults in contact with the criminal justice system (NG66)
This guideline covers assessing, diagnosing and managing mental health problems in adults (aged 18 and over) who are in contact with the criminal justice system. It aims to improve mental health and wellbeing in this population by establishing principles for assessment and management, and promoting more coordinated care planning and service organisation across the criminal justice system.
View recommendations for NG66Show all sections
This guideline sets out an antimicrobial prescribing strategy for acute sore throat. It aims to limit antibiotic use and reduce antimicrobial resistance. Acute sore throat is often caused by a virus, lasts for about a week, and most people get better without antibiotics. Withholding antibiotics rarely leads to complications.
Medical technologies evaluation programme methods guide (PMG33)
Medical technologies evaluation programme methods guide
Show all sections
- 1 Introduction
- 2 The medical technologies evaluation programme
- 3 Selecting and routing technologies
- 4 Principles for developing medical technologies guidance
- 5 Scope
- 6 Evidence and expert advice
- 7 Evidence synthesis and cost-consequence analysis
- 8 Evaluation of the evidence and decision-making by the committee
Guide to the technology appraisal and highly specialised technologies appeal process (PMG41)
Guide to the technology appraisal and highly specialised technologies appeal process
This guideline sets out an antimicrobial prescribing strategy for adults, young people and children aged 72 hours and over with impetigo. It aims to optimise antibiotic use and reduce antibiotic resistance.
NICE research projects and partners.
BD MAX Enteric Bacterial Panel for identifying pathogens in contagious gastroenteritis (MIB32)
NICE has developed a medtech innovation briefing (MIB) on BD MAX Enteric Bacterial Panel for identifying pathogens in contagious gastroenteritis .
Guide to the methods of technology appraisal 2013
Netarsudil-latanoprost for previously treated open-angle glaucoma or ocular hypertension [ID1363]
In development [GID-TA10741] Expected publication date: TBC
come from Black and Minority Ethnic backgrounds. Baseline assessment and patient involvement We completed an initial consultations with...
Evidence-based recommendations on daratumumab (Darzalex) with bortezomib, thalidomide and dexamethasone for untreated multiple myeloma when a stem cell transplant is suitable.
Shared learning database Organisation: Champs Public Health Collaborative Published date: February 2018
Chemotherapy services are delivered across the region. Over seven thousand new patients were treated in 2016-17, of which it is...
Evidence-based recommendations on belumosudil (Rezurock) for chronic graft-versus-host disease in people 12 years and over after 2 or more systemic treatments.
Obsessive-compulsive disorder and body dysmorphic disorder: treatment (CG31)
This guideline covers recognising, assessing, diagnosing and treating obsessive-compulsive disorder and body dysmorphic disorder in adults, young people and children (aged 8 years and older). It aims to improve the diagnosis and treatment of obsessive-compulsive disorder and body dysmorphic disorder. It includes recommendations on how families and carers may be able to support people with either of these conditions, and how they can get support for themselves.
Evidence-based recommendations on afatinib (Giotrif) for treating EGFR-positive locally advanced or metastatic non-small-cell lung cancer in adults.